Analysis of IgG subclass antibodies and expression of T-Cell receptor signaling molecules in anti-CD4 monoclonal antibody treated mice with autoimmune cardiomyopathy

References

• Limas CJ, Goldenberg IF, Limas C. Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy: Correlation with disease severity and cardiac autoantibodies. Circulation 1995; 91: 631–634
   Google Scholar
• Luppi P, Rudert WA, Zanone MM, Stassi G, Trucco G, Finegold D, Boyle GJ, Del Nido P, McGowan FX, Jr., Trucco M. Idiopathic dilated cardiomyopathy: A super ADP/ATP carrieigen-driven autoimmune disease. Circulation 1998; 98: 777–785
   PubMed Web of Science ®Google Scholar
• Ratcliffe NR, Hutchins J, Barry B, Hickey WF. Chronic myocarditis induced by T cells reactive to a single cardiac myosin peptide: Persistent inflammation, cardiac dilatation, myocardial scarring and continuous myocyte apoptosis. J Autoimmun 2000; 15: 359–367
   Google Scholar
• Bozkurt A, Canataroglu A, Cetiner S, Donmez Y, Usal A, Demirtas M. Lymphocyte subsets in patients with idiopathic dilated cardiomyopathy. Anadolu Kardiyol Derg 2001; 1: 98–100
   Google Scholar
• Fu M, Matsui S. Is cardiomyopathy an autoimmune disease?. Keio J Med 2002; 51: 208–212
   Google Scholar
• Matsui S, Fu ML, Katsuda S, Hayase M, Yamaguchi N, Teraoka K, Kurihara T, Takekoshi N, Murakami E, Hoebeke J, Hjalmarson A. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 1997; 29: 641–655
   PubMed Web of Science ®Google Scholar
• Schultheiss HP, Bolte HD. Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 1985; 17: 603–617
   PubMed Web of Science ®Google Scholar
• Ansari AA, Wang YC, Danner DJ, Gravanis MB, Mayne A, Neckelmann N, Sell KW, Herskowitz A. Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy. Am J Pathol 1991; 139: 337–354
   Google Scholar
• Schultheiss HP. Disturbance of the myocardial energy metabolism in dilated cardiomyopathy due to autoimmunological mechanisms. Circulation 1993; 87(Suppl)43–48
   Google Scholar
• schulze K, Becker BF, schauer R, Schultheiss HP. Antibodies to ADP/ATP carrier-an autoantigen in myocarditis and dilated cardiomyopathy-impair cardiac function. Circulation 1990; 81: 959–969
   Google Scholar
• Liao YH, Yuan J, Wang ZH, Cheng X, Zhang JH, Tian Y, Dong JH, Guo HP, Wang M. Infectious tolerance to ADP/ATP carrier peptides induced by anti-L3T4 monoclonal antibody in dilated cardiomyopathy mice. J Clin Immunol 2005; 25(4)376–384
   Google Scholar
• Waldmann H, Cobbold S. How do monoclonal antibodies induce tolerance? A role for infectious tolerance?. Annu Rev Immunol 1998; 16: 619–644
   PubMed Web of Science ®Google Scholar
• Schulze-Koops H, Lipsky PE. Anti-CD4 monoclonal antibody therapy in human autoimmue diseases. Curr Dir Autoimmun 2000; 2: 24–49
   PubMedGoogle Scholar
• Yuan HT, Liao YH, Wang Z, Dong JH, Cao LS, Wang ZH, Wang JP, Fu ML. Prevention of myosin-induced autoimmune myocarditis in mice by anti-L3T4 monoclonal antibody. Can J Physiol Pharmacol 2003; 81: 84–88
   Google Scholar
• Acuto O, Cantrell D. T cell activation and the cytoskeleton. Annu Rev Immunol 2000; 18: 165–184
   PubMed Web of Science ®Google Scholar
• Mozaffari F, Hansson L, Kiaii S, Ju X, Rossmann ED, Rabbani H, Mellstedt H, Osterborg A. Signaling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stage. Br J Haematol 2004; 124: 315–324
   PubMed Web of Science ®Google Scholar
• Maisel A, Cesario D, Baird S, Rehman J, Haghighi P, Carter S. Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after myocardial infarction. Circ Res 1998; 82: 458–463
   PubMed Web of Science ®Google Scholar
• Longo NS, Wang X, Wildin RS, Abraham KM. Regulation of Src-family protein tyrosine kinase transcription during lymphocyte ontogeny. Mol Immunol 1999; 36: 979–992
   Google Scholar
• Liao YH, Cheng LX, Da SP. Autoantibodies against ADP/ATP carrier from patients with dilated cardiomyopathy increase activity of voltage-dependent Ca channels in isolated cardiac myocytes. Blood Press Suppl 1996; 3: 41–44
   Google Scholar
• Staudt A, Bohm M, Knebel F, Grosse Y, Bischoff C, Hummel A, Dahm JB, Borges A, Jochmann N, Wernecke KD, Wallukat G, Baumann G, Felix SB. Potential role of autoantibodies belonging to the immunogolbulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circlulation 2002; 106: 2448–2453
   PubMed Web of Science ®Google Scholar
• Warraich RS, Dunn MJ, Yacoub MH. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: Pro-inflammatory antibodies in DCM patients. Biochem Biophys Res Commun 1999; 259: 255–261
   PubMed Web of Science ®Google Scholar
• Warraich RS, Noutsias M, Kasac IK, Seeberg B, Dunn MJ, Schultheiss HP, Yacoub MH, Kuhl U. Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: Immunoglobulin G3 and clinical correlates. Circulation 2002; 143: 1076–1084
   Google Scholar
• Staudt A, Dorr M, Staudt Y, Bohm M, Probst M, Empen K, Plotz S, Maschke HE, Hummel A, Baumann G, Felix SB. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: Results from protein A immunoadsorption. Am Heart J 2005; 150: 729–736
   PubMed Web of Science ®Google Scholar
• Lapham C, Golding B, Inman J, Blackburn R, Manischewitz J, Highet P, Golding H. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted Balb/C mice. J Virol 1996; 70: 3084–3092
   Google Scholar
• Moran TM, Park H, Fernandez-Sesma A, Schulman JL. Th2 responses to inactivated influenza virus can be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection. J Infect Dis 1999; 180: 579–585
   PubMed Web of Science ®Google Scholar
• Rudd CE. Two-step TCR/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinase. Immunol Today 1994; 15: 225–230
   PubMedGoogle Scholar
• Spertini F, Perret-Menoud V, Barbier N, Chatila T, Barbey C, Corthesy B. Epitope-specific crosslinking of CD45 down-regulates membrane-associated tyrosine phosphatase activity and triggers early signaling events in human activated T cells. Immunology 2004; 113: 441–452
   Google Scholar
• Chan AC, Desai DM, Weiss A. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu Rev Immunol 1994; 12: 555–592
   PubMed Web of Science ®Google Scholar
• Trebake M, Lambert CA, Rahmouni S, Greimers R, Bioniver J, Moutschen M. Reciprocal regulation of protein tyrosine kinases p56lck and p59fyn, and altered tyrosine phosphorylation in murine AIDS. Int Immunol 1998; 10: 1473–1480
   Google Scholar
• Von Knethen A, Abts H, Kube D, Diehl V, Tesch H. Expression of p56lck in B-cell neoplasias. Leuk Lymphoma 1997; 26: 551–562
   PubMed Web of Science ®Google Scholar
• Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwal A, Thomas PW, Hamblin TJ, Staudt LM, Oscier DG. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004; 363: 105–111
   PubMed Web of Science ®Google Scholar
• Gratama JW, Zea AH, Bolhuis RL, Ochoa AC. Restoration of expression of signal-transduction molecules in lymphocytes from patients with metastatic renal cell cancer after combination immunotherapy. Cancer Immunol Immunother 1999; 48: 263–269
   PubMed Web of Science ®Google Scholar
• Takahashi T, Yagi T, Kakinuma S, Kurokawa A, Okada T, Takatsu K, Aizawa S, Katgiri T. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn). J Immunol 1997; 159: 2532–2541
   Google Scholar
• Liu P, Aitken K, Kong YY, Opavsky MA, Martino T, Dawood F, Wen WH, Kozieradzki I, Bachmaier K, Straus D, Mak TW, Penninger JM. The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease. Nat Med 2000; 6: 429–434
   PubMed Web of Science ®Google Scholar
• Waldor MK, Sriram S, Hardy R, Herzenberg LA, Lanier L, Lim M, Steinman L. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science 1985; 227: 415–417
   PubMed Web of Science ®Google Scholar
• Wofsy D, Seaman WE. Reversal of advanced murine lupus in NZB/NZW F1 mice by reatment with monoclonal antibody to L3T4. J Immunol 1987; 138: 3247–3253
   PubMed Web of Science ®Google Scholar